.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Care By Design is stocked at 292 licensed dispensaries across California, with the deepest coverage in Los Angeles, San Francisco, San Jose, Sacramento, and San Diego. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Care By Design’s mix tilted toward Tincture & Sublingual at 47.54% share (ranked 3rd in California Tincture & Sublingual), even as that category declined 14.04% year over year and 3.97% month over month. Vapor Pens expanded to 36.52% share with 14.79% YoY growth but slipped 0.88% MoM, while Capsules held 7.34% share with a 7.59% YoY decline but a 10.19% MoM rebound. Topical and Edible trailed at 4.63% and 3.97% share, with YoY declines of 21.25% and 8.48% and MoM drops of 17.21% and 5.54%, respectively. With brand sales down 5.02% YoY and average price down 4.58% YoY, the pattern implies a reliance on a contracting lead category offset by a growing secondary pillar, which pressures total revenue unless mix shifts further toward the higher-growth segment.
The shift toward Vapor Pens’ 14.79% YoY growth alongside Tincture & Sublingual’s 14.04% YoY contraction suggests margin and volume will increasingly hinge on balancing penetration in a faster-growing inhalable format against defending a still-dominant but shrinking base. The 10.19% MoM rise in Capsules amid a 17.21% MoM Topical pullback indicates consumers are favoring ingestible precision over external applications, implying that portfolio emphasis on dose-controlled formats can stabilize share if paired with calibrated pricing after a 4.58% YoY price decline. Taken together, the mix implies Care By Design can protect its 3rd-place rank in California Tincture & Sublingual while reallocating attention to Vapor Pens and Capsules to counteract the 5.02% YoY brand sales decrease and reduce exposure to categories with double‑digit contractions.
Competitive Landscape
Care By Design holds rank #3 in CA Tincture & Sublingual in August 2026, unchanged from #3 year over year, and also flat versus three months ago at #3; despite a historic peak at #1 in February 2025, the brand’s static position alongside a -1.36% YoY sales decline for Papa & Barkley at #1 and a +15.09% YoY sales gain for Yummi Karma at #2 points to share being squeezed from above and below. With VET CBD steady at #4 and Mary's Medicinals improving from #6 to #5, the upward pressure from ranks #4 and #5 combines with a stable top three to compress mobility; the pattern implies Care By Design’s rank trajectory is locked in the short term unless it reclaims momentum akin to its February 2025 peak, because competitors’ +12.37% and +6.80% YoY growth rates erode the buffer around #3.
Notable Products
The steepest decline came from CBD/THC 1:1 Joint and Muscle Cream (450mg CBD, 450mg THC, 3oz), down 20.5% MoM at rank 7, while the CBD/THC 40:1 Lower THC Tincture (960 CBD, 24mg THC, 30ml) fell 16.1% to rank 3. In contrast, CBD/THC 18:1 Lower THC Full Spectrum Cartridge (1g) rose 11.9% to rank 5 as CBD/THC 1:1 Higher THC Full Spectrum Cartridge (1g) slipped 10.3% to rank 6, indicating mixed traction within Vapor Pens. Four of the top ten are Tincture & Sublingual SKUs, with the CBD/THC 1:1 MAX Peppermint Full Spectrum Tincture (1000mg CBD, 1000mg THC, 15ml) holding rank 1 on a 4.8% MoM gain and the CBD/THC 40:1 Low THC Tincture (480mg CBD, 12mg THC, 15ml) dropping 15.4% at rank 10, pointing to softening demand at the low-THC end despite a stable flagship. Overall, the mix tilts toward maintaining high-THC balanced formats while de-emphasizing low-THC tinctures and non-ingestible topicals, implying a pivot toward inhalable and balanced-dose leaders over niche wellness items.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
